Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2018-08-01 History
Report ID 51084
Drug Identification Number 00436208
Brand name 2% LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE ANSYR
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5mL
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-29
Estimated end date
Actual end date 2018-07-31
Shortage status Resolved
Updated date 2018-08-01
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-08-01 French Compare
v9 2018-08-01 English Compare
v8 2018-07-25 French Compare
v7 2018-07-25 English Compare
v6 2018-07-10 French Compare
v5 2018-07-10 English Compare
v4 2018-06-30 English Compare
v3 2018-06-01 French Compare
v2 2018-06-01 English Compare
v1 2018-06-01 English Compare